Cigarette Smoking, MDM2 SNP309, Gene–Environment Interactions, and Lung Cancer Risk: A Meta-Analysis

REFERENCES

• Bagos , P. G. and Nikolopoulos , G. K. 2007 . A method for meta-analysis of case-control genetic association studies using logistic regression . Stat. Appl. Genet. Mol. Biol. , 6 Epub 2007
   PubMed Web of Science ®Google Scholar
• Bond , G. L. , Hu , W. , Bond , E. E. , Robins , H. , Lutzker , S. G. , Arva , N. C. , Bargonetti , J. , Bartel , F. , Taubert , H. , Wuerl , P. , Onel , K. , Yip , L. , Hwang , S. J. , Strong , L. C. , Lozano , G. and Levine , A. J. 2004 . A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans . Cell , 119 : 591 – 602 .
   PubMed Web of Science ®Google Scholar
• Bond , G. L. , Hu , W. and Levine , A. 2005 . A single nucleotide polymorphism in the MDM2 gene: From a molecular and cellular explanation to clinical effect . Cancer Res. , 65 : 5481 – 5484 .
   PubMed Web of Science ®Google Scholar
• DerSimonian , R. and Laird , N. 1986 . Meta-analysis in clinical trials . Control Clin. Trials , 7 : 177 – 188 .
   PubMed Web of Science ®Google Scholar
• Egger , M. , Davey Smith , G. , Schneider , M. and Minder , C. 1997 . Bias in meta-analysis detected by a simple, graphical test . Br. Med. J. , 315 : 629 – 634 .
   PubMed Web of Science ®Google Scholar
• Hu , Z. , Jin , G. , Wang , L. , Chen , F. , Wang , X. and Shen , H. 2007 . MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: Evidence from 21 case-control studies . Cancer Epidemiol Biomarkers Prev. , 16 : 2717 – 2723 .
   PubMed Web of Science ®Google Scholar
• Hu , Z. , Ma , H. , Lu , D. , Qian , J. , Zhou , J. , Chen , Y. , Xu , L. , Wang , X. , Wei , Q. and Shen , H. 2006 . Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population . Int. J. Cancer , 118 : 1275 – 1278 .
   PubMed Web of Science ®Google Scholar
• Jemal , A. , Siegel , R. , Ward , E. , Murray , T. , Xu , J. , Smigal , C. and Thun , M. J. 2006 . Cancer statistics, 2006 . CA Cancer J. Clin. , 56 : 106 – 130 .
   PubMed Web of Science ®Google Scholar
• Jun , H. J. , Park , S. H. , Lee , W. K. , Choi , J. E. , Jang , J. S. , Kim , E. J. , Cha , S. I. , Kim , D. S. , Kam , S. , Kim , C. H. , Kang , Y. M. , Jung , T. H. and Park , J. Y. 2007 . Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer . Mol. Carcinogen. , 46 : 100 – 105 .
   PubMed Web of Science ®Google Scholar
• Lau , J. , Ioannidis , J. P. and Schmid , C. H. 1997 . Quantitative synthesis in systematic reviews . Ann. Intern. Med. , 127 : 820 – 826 .
   PubMed Web of Science ®Google Scholar
• Li , G. , Zhai , X. , Zhang , Z. , Chamberlain , R. M. , Spitz , M. R. and Wei , Q. 2006 . MDM2 gene promoter polymorphisms and risk of lung cancer: A case-control analysis . Carcinogenesis , 27 : 2028 – 2033 .
   PubMed Web of Science ®Google Scholar
• Lind , H. , Zienolddiny , S. , Ekstrom , P. O. , Skaug , V. and Haugen , A. 2006 . Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer . Int. J. Cancer , 119 : 718 – 721 .
   PubMed Web of Science ®Google Scholar
• Liu , G. , Wheatley-Price , P. , Zhou , W. , Park , S. , Heist , R. S. , Asomaning , K. , Wain , J. C. , Lynch , T. J. , Su , L. and Christiani , D. C. 2008 . Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk . Int. J. Cancer. , 122 : 915 – 918 .
   PubMed Web of Science ®Google Scholar
• Murray , S. A. , Yang , S. , Demicco , E. , Ying , H. , Sherr , D. H. , Hafer , L. J. , Rogers , A. E. , Sonenshein , G. E. and Xiao , Z. X. 2005 . Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors . J. Cell. Biochem. , 95 : 875 – 884 .
   PubMed Web of Science ®Google Scholar
• Park , S. H. , Choi , J. E. , Kim , E. J. , Jang , J. S. , Han , H. S. , Lee , W. K. , Kang , Y. M. and Park , J. Y. 2006 . MDM2 309T>G polymorphism and risk of lung cancer in a Korean population . Lung Cancer , 54 : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Petitti , D.B. 1994 . Meta-analysis, decision analysis and cost-effectiveness analysis , 101 – 103 . New York : Oxford University Press .
   Google Scholar
• Pine , S. R. , Mechanic , L. E. , Bowman , E. D. , Welsh , J. A. , Chanock , S. C. , Shields , P. G. and Harris , C. C. 2006 . MDM2 SNP309 and SNP354 are not associated with lung cancer risk . Cancer Epidemiol. Biomarkers Prev. , 15 : 1559 – 1561 .
   PubMed Web of Science ®Google Scholar
• Pietenpol , J. A. and Stewart , Z. A. 2002 . Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis . Toxicology , 181–182 : 475 – 481 .
   PubMed Web of Science ®Google Scholar
• Shields , P. G. and Harris , C. C. 2000 . Cancer risk and low-penetrance susceptibility genes in gene–environment interactions . J. Clin. Oncol. , 18 : 2309 – 2315 .
   PubMed Web of Science ®Google Scholar
• Thakkinstian , A. , McElduff , P. , D'Este , C. , Duffy , D. and Attia , J. 2005 . A method for meta-analysis of molecular association studies . Stat. Med. , 24 : 1291 – 1306 .
   PubMed Web of Science ®Google Scholar
• Vogelstein , B. , Lane , D. and Levine , A. J. 2000 . Surfing the p53 network . Nature , 408 : 307 – 310 .
   PubMed Web of Science ®Google Scholar
• Weber , H. O. , Ludwig , R. L. , Morrison , D. , Kotlyarov , A. , Gaestel , M. and Vousden , K. H. 2005 . HDM2 phosphorylation by MAPKAP kinase 2 . Oncogene , 24 : 1965 – 1972 .
   PubMed Web of Science ®Google Scholar
• Willis , A. , Jung , E. J. , Wakefield , T. and Chen , X. 2004 . Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes . Oncogene , 23 : 2330 – 2338 .
   PubMed Web of Science ®Google Scholar
• Wu , X. , Zhao , H. , Suk , R. and Christiani , D. C. 2004 . Genetic susceptibility to tobacco-related cancer . Oncogene. , 23 : 6500 – 6523 .
   PubMed Web of Science ®Google Scholar
• Zhang , X. , Miao , X. , Guo , Y. , Tan , W. , Zhou , Y. , Sun , T. , Wang , Y. and Lin , D. 2006 . Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer . Hum. Mutat. , 27 : 110 – 117 .
   PubMed Web of Science ®Google Scholar